As of 2025-12-16, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -1.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is 87.42 mil USD. DTIL's TTM EBITDA according to its financial statements is -81.56 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 15.1x | 13.6x |
| Forward P/E multiples | 21.8x - 37.4x | 29.6x |
| Fair Price | (42.47) - 4.80 | (21.81) |
| Upside | -984.7% - 0.0% | -554.4% |
| Date | EV/EBITDA |
| 2025-12-15 | -1.07 |
| 2025-12-12 | -1.13 |
| 2025-12-11 | -1.11 |
| 2025-12-10 | -1.13 |
| 2025-12-09 | -1.09 |
| 2025-12-08 | -1.06 |
| 2025-12-05 | -1.13 |
| 2025-12-04 | -1.13 |
| 2025-12-03 | -1.14 |
| 2025-12-02 | -1.07 |
| 2025-12-01 | -1.12 |
| 2025-11-28 | -1.25 |
| 2025-11-26 | -1.16 |
| 2025-11-25 | -1.09 |
| 2025-11-24 | -1.16 |
| 2025-11-21 | -1.13 |
| 2025-11-20 | -1.12 |
| 2025-11-19 | -1.08 |
| 2025-11-18 | -1.19 |
| 2025-11-17 | -1.17 |
| 2025-11-14 | -1.38 |
| 2025-11-13 | -1.37 |
| 2025-11-12 | -1.41 |
| 2025-11-11 | -1.41 |
| 2025-11-10 | -1.43 |
| 2025-11-07 | -1.45 |
| 2025-11-06 | -1.53 |
| 2025-11-05 | -1.58 |
| 2025-11-04 | -1.60 |
| 2025-11-03 | -1.79 |
| 2025-10-31 | -2.02 |
| 2025-10-30 | -2.14 |
| 2025-10-29 | -2.09 |
| 2025-10-28 | -2.05 |
| 2025-10-27 | -1.74 |
| 2025-10-24 | -1.61 |
| 2025-10-23 | -1.67 |
| 2025-10-22 | -1.67 |
| 2025-10-21 | -1.69 |
| 2025-10-20 | -1.73 |
| 2025-10-17 | -1.66 |
| 2025-10-16 | -1.59 |
| 2025-10-15 | -1.55 |
| 2025-10-14 | -1.37 |
| 2025-10-13 | -1.29 |
| 2025-10-10 | -1.30 |
| 2025-10-09 | -1.38 |
| 2025-10-08 | -1.32 |
| 2025-10-07 | -1.32 |
| 2025-10-06 | -1.32 |